Cumberland Pharmaceuticals (CPIX) Change in Accured Expenses (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Change in Accured Expenses across 17 years of filings, most recently posting -$1.3 million for Q1 2026.

• Change in Accured Expenses for Q1 2026 came in at -$1.3 million, down 124.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.0 million (up 730.44% YoY), and the FY2025 annual result was $6.7 million, up 776.77% from the prior year.
• Change in Accured Expenses came in at -$1.3 million for Q1 2026 at Cumberland Pharmaceuticals, down from $8.0 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $8.0 million in Q4 2025 to a low of -$3.3 million in Q4 2023.
• The 5-year median for Change in Accured Expenses is $197393.0 (2022), against an average of $1.0 million.
• Across the five-year window, Change in Accured Expenses soared 2957.92% in 2022 and plunged 185.82% in 2024, its largest moves.
• Cumberland Pharmaceuticals' Change in Accured Expenses stood at $5.8 million in 2022, then slumped by 157.46% to -$3.3 million in 2023, then surged by 90.2% to -$324294.0 in 2024, then jumped by 2580.43% to $8.0 million in 2025, then slumped by 116.73% to -$1.3 million in 2026.
• The last three Change in Accured Expenses figures came in at -$1.3 million (Q1 2026), $8.0 million (Q4 2025), and $684224.0 (Q3 2025), per Business Quant data.